Furthermore, previous studies have reported that Kras mutations occur in only 10–15% of gastric cancer cases but are found in approximately 30–50% of colorectal tumors, which may contribute to the observed differences in tumor formation (Won & Choi, 2022). This evidence concerns the gene KRAS and colorectal neoplasm.